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Murine and human primary lymphocytesDepending on their physiological expression level, microRNAs (miRNA) address different target genes, thus have
different biological functions. To identify these, the physiological expression has to be blocked. Here, we describe
the use of inhibitory cholesterol-modiﬁed oligonucleotides (Antagomirs) to inhibit miRNAs selectively in prima-
ry human andmurine T and B lymphocytes. Due to their lipophilic cholesterol tag Antagomirs enter primary lym-
phocytes efﬁciently and quantitatively. We show here that at concentrations of 0.125 to 1 μM, Antagomirs
selectively inhibit expression of their target miRNA up to 99.5% without affecting cell viability.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Sequence-speciﬁc, genetic inhibition of miRNA is the only way to
determine its role in physiology, at the level expressed in a given cell
(Stenvang et al., 2012). So far, introduction of speciﬁc inhibitory
oligonucleotides into the cell had required viral and non-viral transfec-
tion protocols, the latter dependent on cationic lipids, polymer reagents
or electroporation (Mantei et al., 2008). This poses a fundamental prob-
lem for the analysis of miRNA in primary T and B lymphocytes. First,
they are highly refractory to non-viral transfection methods, and sec-
ond, they are activated by viral infection, introducing an artifactual
bias on the analysis of miRNA (Ziegler et al., 2013). Here, we describe
a detailed protocol for the direct introduction of Antagomirs into
murine and human primary T (Stittrich et al., 2010; Haftmann et al.,
2015; Warth et al., 2015) and B lymphocytes (Knoll et al., 2013;
Porstner et al., 2015) solving this fundamental problem. Antagomirs
are 20–25 nucleotide long, single stranded RNA molecules, with a
sequence complementary to an entire mature miRNA (Krutzfeldt
et al., 2005). Their backbone consists of 2′-O-methyl (2′-O-Me) single
stranded oligoribonucleotides and partially modiﬁed phosphorothioate
(PS) linkers. Antagomirs have a cholesterol-tag at their 3′ end, which
enables their efﬁcient direct uptake via the cell membrane into viable
cells. At concentrations of 0.125 to 1 μM, Antagomirs selectively inhibitngszentrum Berlin, Chariteplatz
.
. This is an open access article undertheir target miRNA up to 99.5%, without affecting viability of the T and B
lymphocytes, or activating them.
2. Materials and methods
2.1. Mice
C57BL/6 mice were housed and bred under speciﬁc pathogen-free
conditions. Micewere handled in accordancewith good animal practice
as deﬁned by German animal welfare bodies and sacriﬁced by cervical
dislocation.
2.2. Cell culture
Naïve CD4+ T cells and CD19+ B cells were isolated from spleens of
6–10week oldmice (magnetic activated cell sorting (MACS)microbead
technology, Miltenyi Biotech). For T helper 1 lymphocyte (Th1) polari-
zation, 3 × 106 naïve CD4+ T cells were cultured and stimulated with
plate-bound αCD3/αCD28 (3 μg/ml, eBioscience), in the presence of
irradiated (30 Gy) CD90-depleted splenocytes from C57BL/6 mice as
antigen-presenting cells and recombinant IL-12 (5 ng/ml; R&D Sys-
tems) and anti-IL-4 (11B11) antibody. Under this condition, viable
Th1 cells were restimulated every 6 days for three rounds to induce
repeatedly activated Th1 cells (Haftmann et al., 2015). Ex vivo isolated
murine CD19+ B cells were activated with 1 μg/ml lipopolysaccharide
(LPS). Human peripheral blood mononuclear cells were isolated from
whole blood by density gradient centrifugation and ﬂuorescently
labeled for CD4 and CD19.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Lyophilized Antagomirs were custom synthesized according to
Krutzfeldt et al. (2005) (Dharmacon, GE Healthcare). Antagomir
sequences are as follows: Antagomir-scr 5-mU(*)mC(*)mAmCmGm
CmAmGmAmUmUmCmAmUmAmA(*)mC(*)mG(*)mU(*)-3-Chol; and
Antagomir-148a 5-mA(*)mC(*)mAmAmAmGmUmUmCmUmGmUm
AmGmUmGmCmAmC(*)mU(*)mG(*)mA(*)-3-Chol. All ribonucleo-
tides are 2′-O-methyl modiﬁed (mN) and (*) represents a phospho-
rothioate modiﬁcation of the backbone. At the 3′-end of the
oligonucleotides, a cholesterol molecule was added. Lyophilized
Antagomirs were resolved in RNase-free water at the desired concen-
tration at room temperature for 30 min with slight shaking.
2.4. Antagomir treatment
Naïve or resting primary murine or human T and B lymphocytes as
well as murine repeatedly activated Th1 cells were washed with cold
PBS at 300 g for 8 min. Lymphocytes (up to 1 × 107 cells/ml) were
resuspended in 0.25 volumes of ﬁnal culture volume of serum-free
medium (ACCELL, Dharmacon) supplemented with Antagomir-148a
or Antagomir-scr in different concentrations. Lymphocytes were incu-
bated for 2 h at 5% CO2, 95% humidity and 37 °C. After incubation,
repeatedly activated murine Th1 cells were stimulated with plate-
bound αCD3/αCD28 (3 μg/ml, eBioscience). CD19+ murine B cells
were activated with 1 μg/ml LPS (see also the Cell culture section).
Both cell types were further cultured in RPMI 1640 (Gibco®, Life Tech-
nologies) cell culture medium with 10% FCS, 100 U/ml Penicillin/Strep-
tomycin, 50 μMβ-mercaptoethanol in vitro (RPMIwas added in fourfold
excess to the lymphocytes in the ACCELL/Antagomir medium).
A detailed protocol for Antagomir treatment is provided in Table 1.
2.5. Detection of Antagomir incorporation
Fluorescein-conjugated Antagomirs were used for quantiﬁcation of
Antagomir incorporation and detected by ﬂow cytometry (MACSQuant,
Miltenyi Biotec) or image stream cytometry (Amnis ImageStreamX
MKII, Merck Millipore).
2.6. RNA extraction and quantitative PCR analysis
Total RNA was isolated with Direct-zol RNA kit (Zymo Research).
Mature miR-148a, miR-148b, miR-152, miR-182, miR-320 and U6
small nuclear RNA (snRNA) were detected by quantitative PCR
with a Taqman MicroRNA Reverse Transcription kit in combination
with TaqMan MicroRNA Assays (Life Technologies) according to the
manufacturer's recommendations. For normalization, the expression
values were compared to values of snU6 by the change-in-threshold
method (2−ΔCT) (Haftmann et al., 2015).
Reverse transcription of mRNA was performed using the Reverse
Transcription kit (Life Technologies, Germany) and cDNA was quanti-
ﬁed by SYBR Green based real-time PCR (Roche) using the following
primer pairs: murine hypoxanthine guanine phosphoribosyltransferase
(HPRT) forward 5′-TCCTCCTCAGACCGCTTTT-3′, HPRT reverse 5′-CATA
ACCTGGTTCATCATCGC-3′, murine BIM forward 5′-CCCGGAGATACGGA
TTGCA-3′ and BIM reverse 5′-AACACCCTCCTTGTGTAAGTTTCGT-3′
(Haftmann et al., 2015). For normalization, the expression values were
compared to values of HPRT by the change-in-threshold method
(2−ΔCT) (Livak and Schmittgen, 2001).
3. Results and discussion
Here, we show a simple and reliable method to inhibit the physio-
logical function of miRNA in T and B lymphocytes, which are difﬁcult
to transfect by conventional methods. The introduction of Antagomirs
does not require the use of transfection vehicles or electroporation.Antagomirs act in the cytoplasm by inhibiting the activity of their target
miRNA.
3.1. Efﬁciency of Antagomir uptake in primary murine and human T and B
cells
To introduce Antagomirs into ex vivo isolated murine B and T
lymphocytes, the cells were incubated with ﬂuorescein-conjugated
Antagomir for 2 h in serum-free medium. Uptake of cholesterol-
containing oligonucleotides is highly efﬁcient in serum-free medium
(Petrova et al., 2012). The Antagomir (Antagomir-scr) was designed
not to target any known miRNA (Stittrich et al., 2010; Knoll et al.,
2013; Haftmann et al., 2015; Porstner et al., 2015; Warth et al.,
2015).
Fluorescein-conjugated Antagomir-scr was incorporated in a
concentration dependent manner after 2 h incubation in primary B
and T cells (Fig. 1a). Ex vivo isolated T and B cells had taken up the
Antagomir quantitatively and a ﬂuorescein signal was detectable even
3 days after activation of the cells despite proliferation (Fig. 1b). Strong
ﬂuorescence was detected at d0 and was most likely due to surface-
bound Antagomir-scr which was lost by d1. The Antagomirs taken up
by the cells were detectable within T as well as B lymphocytes and do
not co-localize with CD4 or CD19 surface staining (Fig. 1c). Localization
of Antagomirs in the cytoplasm after in vivo application has been dem-
onstrated by others (Krutzfeldt et al., 2007), and suggests why nuclear
miRNA precursors are not affected by Antagomirs (Krutzfeldt et al.,
2005).
When Antagomirs were applied at concentrations of 1 μM and for
3 h of incubation in serum-free medium, more than 95% of the T and B
lymphocytes were viable, as determined by propidium iodide staining
(Fig. 1d). An increase of the Antagomir concentration to 16 μM resulted
in reduced viability of T cells to below 50%, while still more than 85% of
the B cells were viable. After incubation with Antagomir concentrations
of 1 μM cell viability is maintained over several days allowing for
functional assays in vitro or adoptive cell transfer in murine models
(Stittrich et al., 2010; Knoll et al., 2013; Haftmann et al., 2015;
Porstner et al., 2015;Warth et al., 2015). Contrastingly, the introduction
of antisense oligonucleotides by nucleofection or lipofection results in
high variability in terms of efﬁciency and negatively affects cell viability
and are therefore less reliablemethods formiRNA knockdown in exper-
imental settings.
3.2. Efﬁciency and speciﬁcity of miRNA-knockdown by Antagomir
treatment
To assess the speciﬁc on-target activity of Antagomirs taken up by T
and B lymphocytes, we used a non-ﬂuorescently labeled Antagomir
targeting miR-148a (Antagomir-148a). miR-148a is highly expressed
in repeatedly activated murine Th1 lymphocytes following restimula-
tion with anti-CD3 and anti-CD28 antibodies (reactivated 4 times in
weekly intervals) (Haftmann et al., 2015) and in LPS-activated CD19+
B lymphocytes (Porstner et al., 2015). Repeatedly activated Th1
cells were incubated for 2 h in serum-free medium with Antagomir-
148a, a non-targeting non-ﬂuorescently labeled control Antagomir
(Antagomir-scr) or without Antagomir (Incubation ctrl). Expression of
miR-148a was quantitated by real-time PCR analysis. Expression of
miR-148a was inhibited selectively and in a dose-dependent fashion
by the Antagomir-148a at concentrations between 0.125 and 1 μM in
both T and B lymphocytes. Expression of miR-148a was completely
blocked in T lymphocytes at 1 μM, and inhibited by 87% in B lympho-
cytes at 2 μM (Fig. 2a, b). Inhibition of miR-148a results in an about 2-
fold increase in the mRNA level of its target gene Bim, already at a
concentration of 0.125 μM Antagomir-148a (Fig. 2c), demonstrating
the speciﬁc Antagomir effect on miRNA function primarily via RNAi-
independent degradation of miRNA (Krutzfeldt et al., 2007). For
miRNA with unknown target genes, we suggest to use reporter gene
Table 1
Protocol — procedure and timing.
Protocol Comments
Pre-incubation of lymphocytes with Antagomirs, timing 2.5 h
1 Wash lymphocytes (naïve or resting primary T or B cells) with cold PBS and
centrifuge at 300 g for 8 min.
2 Resuspend lymphocytes (up to 1 ∗ 107 cells/ml) in 0.25 volumes of ﬁnal culture
volume of serum-free medium, e.g., ACCELL (Dharmacon) (i.e., if cell culture is
carried out in 5 ml, resuspend lymphocytes in 1.25 ml serum-free medium).
Critical: serum-free medium increases the efﬁciency of Antagomir uptake from the
medium. The cholesterol-coupled Antagomirs will attach to the cell surface and are
subsequently incorporated.
3 Dilute Antagomirs at the desired and titrated concentration. Critical: even at only moderate miRNA knockdown efﬁciency there may already
be visible phenotypical changes and impact on potential targets. Too high
concentrations of Antagomirs may lead to off-target effects. Therefore, a titration
of the Antagomirs and determination of suitable analysis time points in different
culture settings is highly recommended prior to experimental procedures.
4 Gently mix samples and incubate for 2 h at 5% CO2, 95% humidity and 37 °C.
Meanwhile prepare stimulating and differentiating medium for further cell culture.
Stimulation and culture of Antagomir-treated lymphocytes in vitro
5 Add 0.75 volumes of serum-containing culture medium supplemented with all
necessary cytokines and stimuli to culture wells/plates (e.g., in this study,
repeatedly activated Th1 cells were restimulated with plate-bound αCD3/αCD28
and recombinant IL-12 and anti-IL-4 antibody).
Antagomir uptake does not depend on reactivation of lymphocytes. Resting
lymphocytes treated with Antagomirs can also be monitored (e.g., Fig. 1d) and
analyzed.
6 Add 0.25 volumes of Antagomir-treated cells to the medium and incubate at 5%
CO2, 95% humidity and 37 °C for the desired time.
Critical: Determine the most suitable analysis time point prior to experimental
procedures, e.g., by expression kinetics of miRNA, target genes and usage of reporter
gene assays.
Control knockdown efﬁciency by quantitative real-time PCR analysis
7 At the end of the experimental procedure, perform the desired analysis and take an
aliquot of the cells to determine knockdown efﬁciency of Antagomirs (and their
potential impact on targets) by qRT-PCR analysis or Northern Blots
(and/or protein detection).
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2006). Such reporter constructs have speciﬁc miRNA binding sites
in their 3′ untranslated region and are subsequently subjected to
miRNA-mediated downregulation, which should be restored by
Antagomir treatment (Davis et al., 2006).
To determine the optimal incubation time formiR-148a knockdown,
repeatedly activated Th1 lymphocytes were incubated in serum-free
medium with either 1 μM Antagomir-148a or Antagomir-scr from
5 min up to 4 h. After the various incubation periods, cells were further
stimulated with αCD3 and αCD28 antibodies for 3 days. Expression
of miR-148a was inhibited by 99.5% after an incubation time of 2 h
and resembled miR-148a levels observed in repeatedly reactivated
Th1 lymphocytes before restimulation (Fig. 2d). Five minutes of in-
cubation with Antagomirs is sufﬁcient to achieve a ~94% knockdown
of miR-148a three days after activation. This may be sufﬁcient for ex-
periments in which prolonged serum starvation leads to massive cell
death.
The speciﬁcity of Antagomir action was assessed by comparing the
impact of Antagomir-148a treatment on the levels of miR-148a, miR-
148b, miR-152, miR-182 and miR-320 in repeatedly reactivated T lym-
phocytes. Mir-148a, miR-148b and miR-152 share the same seed se-
quence (Fig. 2e). Antagomir-148a inhibited expression of miR-148a by
98%, miR-148b by 80% and miR-152 by 60%. Expression of miR-182
and miR-320 was not inhibited (Fig. 2f). Knockdown of the target
miRNA is highly sequence-speciﬁc and miRNAs with unrelated se-
quence remain unaffected. Even two (miR-148b) or three mismatches
(miR-152) (Fig. 2e) in closely related miRNA sequences reduce the
knockdown efﬁciencies markedly. Off-target effects on miRNA with re-
lated sequences must be tested for each individual Antagomir. Of note,
the efﬁciency of miRNA knockdown can be alternatively tested byFig. 1. Antagomirs efﬁciently enter primary lymphocytes, are localized in the cytoplasm and
unstimulated CD4+ T cells and unstimulated CD19+ B cells were treated with ﬂuorescein-coup
without addition of Antagomir (Incubation ctrl). a) Cells were treated with concentrations of 0
rescence was analyzed by ﬂow cytometry; b) cells were treated with a concentration of 1 μM o
FCS-containingRPMImedium for 3 days andﬂuorescencewas analyzedbyﬂowcytometry, d0=
scr in live murine CD4+ T cells, murine CD19+ B cells, human CD4+ T cells and human CD19+
MKII, MerckMillipore) 24 h after incubationwith Antagomirs, BF— brightﬁeld, CD4/CD19— su
different concentrations of Antagomir-scr in serum-free medium for 2 h. Viability was determin
were incubated in serum-free medium without addition of Antagomir.Northern Blots (Krutzfeldt et al., 2005; Davis et al., 2006) instead of
quantitative real time-PCR (qRT-PCR).
Antagomirs are suitable for selective miRNA inhibition in resting as
well as activated lymphocytes. This method is efﬁcient, highly repro-
ducible and Antagomirs are incorporated to the same extent in all
cells of a particular subset already after a short incubation period. In
contrast, by conventional transfection- or electroporation-based
methods, oligonucleotides are taken up by only by a fraction of the
cells. Thus, we suggest the use of Antagomirs for miRNA inhibition in
primary T and B cells as the method of choice in functional studies.
We provide a typical work-ﬂow in Table 1 and suggestions for manag-
ing experimental difﬁculties and troubleshooting are listed in
Appendix A.
Author contribution
CH and RR established the protocol, designed and performed the ex-
periments, analyzed thedata andwrote themanuscript. JWandMPper-
formed experiments. HDC and AR supervised the research and wrote
themanuscript andMFM supervised the research, discussed the results,
analyzed the data and wrote the manuscript.
Conﬂict of interest
The authors declare no conﬂicting interest in this work.
Acknowledgments
This work was supported by the Deutsche Forschungsgemeinschaft
(SFB 650 and SFB 633), the IMI JU funded project BTCure, no 115241,show low cytotoxicity. Ex vivo isolated (MACS Technology, Miltenyi Biotech, Germany)
led non-targeting control Antagomir (Antagomir-scr) or incubated in serum-free medium
.125 to 2 μMof ﬂuorescein-coupled Antagomir-scr for 2 h in serum-free medium and ﬂuo-
f ﬂuorescein-coupled Antagomir-scr, washed after 2 h of incubation with PBS, cultured in
cells after 2 h of incubation; c) cytoplasmic localization ofﬂuorescein-coupled Antagomir-
B cells was determined by single cell immunoﬂuorescence analysis (Amnis ImageStreamX
rface staining; d) viability ofmurine CD4+ Th1 cells and CD19+ B cells after treatmentwith
ed by propidium iodide staining, analyzed by ﬂow cytometry and normalized to cells that
131C. Haftmann et al. / Journal of Immunological Methods 426 (2015) 128–133the FORSYS (Forschungseinheiten zur Systembiologie) program and
the “e:Bio — Innovationswettbewerb Systembiologie” program of
the Federal Ministry of Education and Research, and the European
Research Council (ERC) Advanced Grant (ERC-2010-AdG_20100317Grant 268987). RR is a member of the Berlin-Brandenburg School
of Regenerative Therapies (BSRT, DFG-GSC203). CH is a member of
the International Max Planck Research School for Infectious Diseases
and Immunology (IMPRS-IDI).
Fig. 2. Antagomirs silence miR-148a with a concentration-dependent efﬁcacy in T and B cells and with high miRNA speciﬁcity. miR-148a expression was analyzed in
a) repeatedly activated Th1 cells (Niesner et al., 2008; Haftmann et al., 2015) on day 3 after reactivation with 3 μg/ml of plate-bound αCD3/αCD28 and b) ex vivo isolated
CD19+ B cells on day 4 after activation with 1 μg/ml LPS. The cells were treated with indicated concentrations of Antagomir-148a, a non-targeting control Antagomir
(Antagomir-scr) or incubated in serum-free medium without addition of Antagomir (Incubation ctrl). miRNA expression was determined by qRT-PCR analysis and normalized
to small nuclear RNA U6 (snU6); c) analysis of Bim expression on day 3 after restimulation of repeatedly activated Th1 cells treated with various concentrations of Antagomir-
148a, Antagomir-scr or without Antagomir (Incubation ctrl), determined by qRT-PCR analysis and normalized to hypoxanthine-guanine phosphoribosyltransferase (HPRT)
expression; d) miR-148a expression in repeatedly activated Th1 cells (Niesner et al., 2008; Haftmann et al., 2015) on day 3 after reactivation either treated with 1 μM
Antagomir-148a or Antagomir-scr during different incubation times in serum-free medium in comparison to repeatedly activated Th1 cells before restimulation (Th1 rep.
w/o). Repeatedly activated Th1 cells were restimulated with 3 μg/ml of plate-bound αCD3/αCD28; e) sequence homology of miR-148a, miR-148b and miR-152 and comple-
mentarity to Antagomir-148a (red indicates the miRNA seed region and blue the mismatches between miR-148b and miR-152 compared to miR-148a); f) expression levels of
miR-148a, miR-148b, miR-152, miR-182 and miR-320 in repeatedly activated Th1 cells treated with 1 μM Antagomir-148a or Antagomir-scr on day 3 after restimulation with
3 μg/ml of plate-bound αCD3/αCD28, determined by qRT-PCR analysis and normalized to snU6.
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No phenotypical change No efﬁcient silencing of speciﬁc miRNA Check for knockdown efﬁciency, if no knockdown can be observed, see “No change
in miRNA levels” section
No impact on target Divergent target expression proﬁle Compare miRNA and target expression (mRNA and protein) kinetics and
determine suitable analysis time point (impact on target mRNA and protein may
vary)
No efﬁcient silencing of speciﬁc miRNA Check for knockdown efﬁciency, if no knockdown can be observed, see “No change
in miRNA levels” section
No change in miRNA levels Antagomir does not have the correct speciﬁcity
for the miRNA
Control Antagomir sequence
No functional Antagomir Measure concentration of Antagomir in stock solution to ensure it was not
degraded during reconstitution and/or shipment
Always resuspend Antagomirs in RNase-free water, Antagomirs are extremely
susceptible to RNase-mediated degradation
No efﬁcient silencing by Antagomir Increase Antagomir concentration (some miRNAs have a high abundance and may
therefore need higher concentrations of Antagomirs or a later analysis time point
for optimal knockdown effect)
Increase incubation time in FCS-free medium
Decrease cell number
Test different analysis time points (Antagomirs should enter cells already shortly
after treatment. If analysis time point is very late, miRNA levels could be already
restored. Alternatively, highly abundant miRNAs may need a longer time period to
be sufﬁciently knocked down)
Divergent miRNA expression proﬁle Deﬁne the expression kinetics of miRNA to determine suitable analysis time point
Only mild change in miRNA
levels
Inefﬁcient knockdown Increase Antagomir concentration (some miRNAs have a high abundance in the
cells and may therefore need higher concentrations of Antagomirs or a later
analysis time point for optimal knockdown effect. In addition, strong stimuli lead
to an exacerbated proliferation and dilution of the Antagomir)
Increase incubation time
Decrease cell number
Test different analysis time points (Antagomirs should enter cells already shortly
after treatment. If analysis time point is very late, miRNA levels could be already
restored. Alternatively, highly abundant miRNAs may need a longer time period to
be sufﬁciently knocked down)
Antagomirs are competitively taken up by non-target
cells in the culture
Increase Antagomir concentration
Change the ratio of target cells to non-target cells
Remove non-target cells during Antagomir treatment
No miRNA detection Loss of miRNA during RNA puriﬁcation Use miRNA-speciﬁc RNA prep system
Cells died during culture Cells are very sensitive to serum starvation Decrease incubation time
Treat with rich medium, e.g., medium supplemented with ITS liquid media (Sigma
Life Science, Germany) supplement in the ﬁnal cell culture medium
Titrate low amounts of serum into pulse medium to ﬁnd optimal balance of miRNA
knockdown and cell viability
Exchange medium to provide fresh nutrients
Decrease cell culture durationReferences
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